ViiV Healthcare gets FDA breakthrough therapy status for HIV prevention drug cabotegravir

ViiV Healthcare has secured FDA breakthrough therapy status for HIV prevention drug cabotegravir. (Credit: Darwin Laganzon from Pixabay)